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7RESEARCH ARTICLE Open AccessDo different anesthesia regimes affect
hippocampal apoptosis and neurologic deficits in
a rodent cardiac arrest model?
Stepani Bendel1,2, Dirk Springe1, Adriano Pereira1, Denis Grandgirard3, Stephen L Leib3,4, Alessandro Putzu1,
Jannis Schlickeiser1, Stephan M Jakob1, Jukka Takala1 and Matthias Haenggi1*Abstract
Background: Different anesthesia regimes are commonly used in experimental models of cardiac arrest, but the
effects of various anesthetics on clinical outcome parameters are unknown. We conducted a study in which we
subjected rats to cardiac arrest under medetomidine/ketamine or sevoflurane/fentanyl anesthesia.
Methods: Asystolic cardiac arrest for 8 minutes was induced in 73 rats with a mixture of potassium chloride and
esmolol. Daily behavioral and neurological examination included the open field test (OFT), the tape removal test
(TRT) and a neurodeficit score (NDS). Animals were randomized for sacrifice on day 2 or day 5 and brains were
harvested for histology in the hippocampus cornus ammonis segment CA1. The inflammatory markers IL-6, TNF-α,
MCP-1 and MIP-1α were assessed in cerebrospinal fluid (CSF). Proportions of survival were tested with the Fisher’s
exact test, repeated measurements were assessed with the Friedman’s test; the baseline values were tested using
Mann–Whitney U test and the difference of results of repeated measures were compared.
Results: In 31 animals that survived beyond 24 hours neither OFT, TRT nor NDS differed between the groups;
histology was similar on day 2. On day 5, significantly more apoptosis in the CA1 segment of the hippocampus was
found in the sevoflurane/fentanyl group. MCP-1 was higher on day 5 in the sevoflurane/fentanyl group (p = 0.04).
All other cyto- and chemokines were below detection threshold.
Conclusion: In our cardiac arrest model neurological function was not influenced by different anesthetic regimes;
in contrast, anesthesia with sevoflurane/fentanyl results in increased CSF inflammation and histologic damage at
day 5 post cardiac arrest.
Keywords: Cardiac arrest, Rats, Sevoflurane, Fentanyl, Ketamine, Medetomidine, NeuroprotectionBackground
Sudden cardiac arrest (CA) is the most important cause
of global cerebral ischemia. Only a minority of resuscitated
patients are discharged in good neurological condition [1].
After CA, the most relevant factor contributing to recovery
is the time interval between collapse and initiation of
resuscitation efforts and the return of spontaneous
circulation (ROSC). Despite community wide efforts
to improve the chain of survival, most patients will
not regain consciousness after ROSC, indicating some* Correspondence: matthias.haenggi@insel.ch
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unless otherwise stated.degree of neuronal injury after transient ischemia.
However, neuronal injury is not uniformly distributed,
and follows a time course [2]. Vulnerable brain areas
(thalamic reticular nucleus, hippocampal cornus ammonis
sector, caudate nucleus and cerebellar Purkinje cells)
demonstrate delayed neuronal degeneration with charac-
teristic signs of apoptosis [2]. This delayed neuronal
degeneration theoretically opens a window of opportunity
to mitigate the devastating effects of ischemia on the
brain. Despite multiple efforts to alter this pathway, the
only neuroprotective measure that has profound effect on
survival and functional outcome after CA is hypothermic
[3,4] or normothermic [5] targeted temperature control.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with induction of CA of different duration by either
ventricular fibrillation (6–12 minutes) [6,7], asphyxiation
(6–12 minutes) [8], hypothermia (30 min) [9], injection of
potassium chloride or other cardioplegic agents (5–6 min)
[10]. Whereas all these models simulate the same global
brain ischemia, the anesthesia methods differ mainly in
two ways: use of intraperitoneal (IP) barbiturates [6,9] or
anesthetic vapors [7,9,10]. Both barbiturates and volatile
anesthetics have, at least to some degree, neuroprotective
properties [11], thus potentially influencing the results of
experimental CA models. Most comatose survivors of
cardiac arrest in the intensive care unit need sedative
drugs to facilitate mechanical ventilation and reduce
sympaticotonic vegetative burden. No formal guidelines
exist for this clinical situation, so various regimes are used
[12]. Due to technical limitations, vapor anesthetics have
been introduced only lately in this patient group [13].
During implementation of a rodent CA model in our
lab, we evaluated the effects of two different anesthetic
regimes on brain damage, defined by brain histology and
inflammatory markers in the cerebrospinal fluid, and on
neurologic deficits, examined by behavioral tests. We
choose the volatile anesthetic sevoflurane in combination
with fentanyl, which is considered displaying at least some
neuroprotective properties [11]. The comparator was a
standard rodent anesthesia regime with the α-agonist
medetomidine in combination with ketamine. We
hypothesized that cardiac arrest with the sevoflurane
based anesthesia would provide more neuroprotection
than the IP administrated anesthesia.Methods
The study was approved by the Animal Care and
Experimentation Committee of the Canton of Bern,
Switzerland and followed the Swiss national guidelines
for the performance of animal experiments. We used
130 male, 10 weeks old Wistar rats (Janvier-Labs,
Isle-St-Genest, France) weighting 389 ± 37 g, which were
housed in the core animal facilities of the University of
Bern with a 12/12 h light/dark cycle at 22°C, with food
and water ad libitum.Pilot phase
Of the total of 130 rats, 57 were used to test different
cardiac arrest times of 6, 7, 7.5, and 8 minutes by either
induction of ventricular fibrillation or asystole. In these
pilot series we could not establish sustained ROSC after
induction of ventricular fibrillation, so we used the
potassium/esmolol-induced asystolic CA as described
below. After establishing 8 minutes as the target, the
remaining 73 rats were included in the study to
evaluate the damage and recovery after cardiac arrest.Study procedures - overview
The study protocol consisted of induction of anesthesia,
surgical preparation, adjustment of mechanical ventilation
based on post-surgery blood gas analysis, induction of
cardiac arrest for 8 minutes, resuscitation, and behavioral
follow-up after successful resuscitation for 1, 2, or 5 days.
At the end of follow up, the animals were euthanized and
brain tissue was harvested for analyses from animals
followed up for 2 and 5 days.
Allocation
The animals were anesthetized either with sevoflurane/
fentanyl (sev/fent) or medetomidine/ketamine (med/ket).
Assignment to the different anesthesia groups was not
randomized for logistic reasons: the vaporizer was only
available at certain days. At these days, the ventilator
stayed configured for the vaporizer and no experiments of
the other group were conducted and vice versa. Assignment
to duration of follow up was decided simultaneously with
the anesthesia regime before the experiment, and an even
distribution between groups was pursued. No cross-over
after assignment was allowed. However, because low overall
survival rates, we decided to abandon the day one follow up
and to redistribute the remaining animals into the 2 and
5 days follow-up.
Anesthesia and surgery
Animals in the sevoflurane/fentanyl group (sev/fnt) were
placed in an induction chamber with 6% sevoflurane
(Sevorane, Abbott Switzerland), with an additional dose
of fentanyl (Fentanyl, Janssen-Cilag, Switzerland) 20 μg/kg
intraperitoneally (IP). The animals in the medetomidine/
ketamine (med/ket) group received IP a mixture of
0.25 mg/kg Medetomidine (Medetor, Virbac Switzerland)
and 60 mg/kg ketamine (Ketalar, Pfizer Switzerland).
Orotracheal intubation was performed with an angiocath
2.0 mm diameter (Venflon, BD Germany) and the position
was confirmed by capnography (Datex S/5 Anaesthesia
Monitor, GE, Helsinki, Finland). Animals were ventilated
with a pressure-controlled, time-cycled ventilator (KTR-5,
Hugo-Sachs Elektronik, March, Germany). The initial
ventilator settings were 50 breaths per minutes, 30%
oxygen/air mix, an inspiratory pressure of 12 cm H2O,
and a PEEP of 3 cm H20. After stabilization (10 minutes),
blood gases were analyzed and the inspiratory pressure of
the ventilator adapted to achieve normoventilation. To
spare blood, no further blood gas analysis was performed
before cardiac arrest. The animals were fixed on a
surgical heating pad, a thermometer was placed into
the esophagus, and the animals were warmed to 36°.
Subcutaneous ECG electrodes were placed on standard
positions. The right femoral artery was exposed and a PE
50 catheter for blood pressure monitoring and blood
sampling was inserted. Another PE 50 catheter for drug
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operations were done by either MH or DS. Time
from anesthesia induction to start surgery took about
15 minutes in the med/ket group and 10 minutes in
the sev/fnt group. The surgical procedure was about
20 minutes in length. Recordings of ECG, arterial
blood pressure and temperature were performed with
a standard anesthesia monitor (Datex S/5 Anaesthesia
Monitor, GE, Helsinki, Finland) and the Wincollect
data logger (GE, Helsinki, Finland) at a rate of 100 Hz.
Cardiac arrest and resuscitation
The rats were paralyzed with 2 mg/kg body weight
vecuronium (Norcuron, MSD, Switzerland) via the jugular
vein catheter to suppress agonal breathing during the
experiment. Cardiac arrest was induced with a mixture of
potassium chloride and esmolol (Esmolol-Orpha, OrPha
Swiss, Switzerland). The rational for adding esmolol was
to lower the total amount and the concentration of the
KCl solution, as done for cardioplegia in human cardiac
surgery. The final solution had a concentration of
0.2 mmol/ml KCl and 9 mg/ml esmolol. Initially, a dose of
2 ml/kg body weight (BW) was given until cardiac arrest
followed, indicated by a drop of the arterial blood pressure
below 15 mmHg, which occurred in all animals within
5 seconds. If electrical cardiac activity in the ECG was
present, immediately an additional dose of the mixture
was added (up to totally 1 ml). The catheter was flushed
with 0.2 ml of a 0.02 mmol/ml KCl solution. This lower
concentrated KCL flush- solution was used to avoid
“auto-resuscitation” which occurs when some spontaneous
very weak contractions of the heart, sometimes ensuing
about 1–2 minutes after cardiac arrest, increase in strength
and frequency. Ventilation was disconnected, and the
heating lamp turned off. After 7.5 minutes, the heating
lamp was turned on, the ventilator was reconnected, a
recruitment maneuver performed (sustained inspiratory
pressure of 20 mmH2O), and ventilation resumed with
55 breaths per minute and 100% oxygen. At 8 minutes,
manual metronome guided chest compression with 2
fingers at a rate of 220/min were started. The chest
compression were made always by the same two operators,
compression depth was about 25 percent of the anterior–
posterior diameter of the chest with complete recoil, and
targeted to achieve a mean artery pressure (together with
adrenaline) of 50 – 55 mmHg. Diluted adrenaline 15 μg/kg
(Adrenalin Bichsel, Switzerland) and 0.2 ml of a
diluted calcium solution containing 0.1125 mmol Ca/ml
(Calcium-Sandoz, Sandoz, Switzerland) were injected at
the beginning of resuscitation maneuvers, separated by
0.1 ml of normal saline. If ROSC was not achieved within
60 seconds, adrenaline was repeated with 5 μg/kg every
30 seconds until ROSC. Calcium was repeated after
2 minutes of resuscitation. ROSC was defined as regularcardiac activity > 200 beats per minute with a mean
arterial pressure of ≥ 60 mmHg sustaining for at least
20 seconds (one monitor length). If ROSC was not
achieved within 4 minutes, no further resuscitation
attempts were made.
After successful resuscitation, ventilation was increased
to 70 breaths per minute, with inspiratory pressures of
18–20 mmH2O, and the rats received 50 mg/kg BW
ampicillin (Clamoxyl, GlaxoSmithKline, Switzerland) for
perioperative antibiotic prophylaxis and 20 μg/kg BW
buprenorphine (Temgesic, Reckitt Benckiser, Switzerland)
as pain relieve intramuscularly. The animals in the sev/fnt
group received 0.6 to 0.8% sevoflurane once hemodynamics
were stable, the concentration was targeted accordingly
to avoid excessive hypertension and ventilator dyssynchro-
nicity. Blood for arterial blood gases were drawn at
ROSC +5 min and ROSC + 15 min. The catheters
were withdrawn immediately afterwards, the wounds
closed and the mechanical ventilation weaned within
the following 15 minutes. The still comatose rats were
placed on a heating mattress, without additional oxygen.
After 4 hours, the rats were returned into a single cage
with access to water and food ad libitum.
Follow-up after resuscitation
Animals were followed according the Animal Care and
Experimentation Committee of the Canton of Bern for
general health, including daily weight measurement with
an electronic balance.
Neurological functions were assessed daily from day 1
to day 5 with an established wide-ranging neuroscore
(NDS) [14]. The NDS evaluates general behavior and
respiration (maximum, 40 points), cranial nerves function
(maximum, 20 points), sensitivity to tactile stimuli
(maximum, 10 points), motor function (maximum, 10
points), and coordination (maximum, 20 points).
To assess gross locomotor abilities, a modified simple
vertical pole test [15] was used. The test scores the
capability of the animals to move along a horizontal
wooden spar of 1.5 cm width, followed by stepwise
elevation of the bar to 45° to 90°, with the animal still
on it. Inability to move along the horizontal spar (0°)
scored 3, keeping at 90° scored 0.
To evaluate sensorimotor integration, the Tape Removal
Test was used [16]. This test measures the time needed to
successfully remove a standard (10×12 mm) adhesive tape
attached to the front paw of the animals (maximum
120 seconds).
To determine the general activity level, the Open Field
task was used [17]. Assessment took place in a square
(0.75 × 0.75 m), wooden box, with the floor divided by
marks in 25 squares. The animals were placed in the
arena and allowed to freely move for 4 minutes while
being recorded by an overhead camera. Normal behavior
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arena, including doing rears to investigate the surroundings.
Accordingly, we analyzed footage by hand counting the
squared crossed (with at least three paws) and rears.
Euthanasia and histology
In order to estimate neuronal damage consecutive to
cardiac arrest and resuscitation, animals were euthanized at
day 1, day 2 or day 5 with an overdose of pentobarbital
intraperitoneally. Then the animal was transcardially
perfused via the left ventricle with 150 ml of buffered
formalin 4% in PBS (Hospital pharmacy Inselspital Bern,
Switzerland). A vertical midline incision extending from the
level of the cervical-cranial junction to the tip of the nose
was performed with scissors. The skull edges were retracted
with forceps so that the exposed brain could be removed
intact. Brains were post-fixed in buffered formalin 4% in
PBS for 24 hours at 4°C. The brains were then transferred
to an 18% sucrose solution in PBS at 4°C until further
processing.
Histological cryo-sections were obtained by cutting the
brain (45 μm thick coronal sections) using a Leica CM
1850 cryostat, after snap freezing of the brain in methyl-
butane pre-cooled at −80°C. Injury to the hippocampus
was determined by histomorphometry on 4 sections of
different hippocampal regions (from rostral to caudal,
therefor examining mostly the dorsal part of the cornus
ammoni 1 (CA1 segment) stained with cresyl violet [18].
Histological sections were scanned at a resolution of
2700 dpi using a dia scanner (Polaroid SprintScan 35
Plus). Atrophy of the cornus ammoni 1 cell layer, resulting
from neuronal loss was determined using the software
ImageJ 1.45 l (National Institutes of Health, USA,
http://imagej.nih.gov/ij). For this aim, the area of the
CA1 subfield stained by cresyl violet was determined.
To correct for differences in the length of the CA1
between sections, normalization was performed by
dividing the calculated surface by the length of the
structure, determined at its border proximal to the
dentate gyrus, and expressed as cell layer ratio (area/
length). Furthermore, the percentage of cells with
apoptotic morphology (pyknotic nucleus, shrunken
appearance) was estimated in the CA1 region of the
same 4 sections by visual observation under a bright-field
microscope, and reported as % pyknotic cells. Because
the rostral/septal portion of the hippocampus is espe-
cially vulnerable, the two rostral/septal and the two
caudal/temporal segments were analyzed separately.
The correlation between atrophy and apoptosis was
estimated with the Pearson’s correlation coefficient
(see below).
All histopathological evaluations were performed by the
same investigator blinded to the clinical and treatment
data of the respective animal.Cerebrospinal fluid assessment
Cerebrospinal fluid was obtained by puncture of the cisterna
magna with a 26 gauge injection needle via the suboccipital
access after the pentobarbital injection was given. Between
50 and 80 μl of CSF could be harvested, immediately
centrifuged and then stored at −80°C until further
examination. Measurement of cytokines/chemokines
concentrations in the undiluted CSF samples was per-
formed using the suspension array technology (http://www.
luminexcorp.com), using a Millipore MILLIPLEX MAP Rat
Cytokine/Chemokine Magnetic Bead Panel (Millipore AG,
Zug, Switzerland). Quantification was based on the use of
standard curves for each analyte. Concentrations of cyto-
kines were calculated using Bio-Plex Manager Software 4.1
(Bio-Rad Laboratories) with a 5-parameter logistic curve-
fitting method. The cytokines/chemokines measured were:
interleukin 6 (IL-6, lower limit of detection 30.7 pg/ml);
TNF-α (lower limit of detection 1.9 pg/ml); monocyte
chemoattractant protein-1 (MCP-1, lower limit of detection
9.0 pg/ml) and macrophage inflammatory protein-1α
(MIP-1α, lower limit of detection 0.8 pg/ml).
Statistics
Because of the small numbers in the groups, non-normal
distribution was assumed. Data are presented as medians
and [IQR]. Proportions of survival were analyzed with the
Fisher’s exact test. Baseline values were compared using
Mann–Whitney U test. Repeated measurements were
assessed with Friedman test. Either significant or insignifi-
cant Friedman tests in both groups were interpreted as indi-
cating no differences between groups, whereas a significant
test in one together with an insignificant test in the other
group as indicating a difference between groups. In order to
have the same number of general health and neurologic test
assessments from all animals, primarily only baseline, first
and last days’ assessment were used for the statistical
analysis. In order to evaluate potential changes between day
2 and day 5 in the group with the longest survival, a separ-
ate Friedman Test was performed in this group of animals
including assessment from days 2 to 5. Pre-cardiac arrest
blood gases were not included in the statistical analysis
because the ventilator settings were adapted afterwards but
the effect on blood gases not measured thereafter. The
non-parametric Pearson correlation test was used to
estimate the correlation between both histomorphometric
methods (amount of cells with apoptotic morphology
resulting in CA1 atrophy and normalized surface). A
p < 0.05 was considered as significant. The calculations
were performed using SigmaPlot/SigmaStat 12.5 (Systat
Software GmbH, Erkrath, Germany).
Results and discussion
From the 73 animals that entered the experiment,
cardiac arrest was induced successfully in 69. Return of
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(84%) and of those with ROSC 31 (53%) survived for
more than 24 hours (Figure 1). The 27 animals which
survived < 24 hours almost all died within the first
6 hours, after presenting an increasing rapid shallow
breathing pattern, indicating atelectasis. There was no
difference between the anesthesia regimens in success
to achieve cardiac arrest and ROSC (med/ket 28 of 35 vs
sev/fnt 30 of 34, p = 0.51), in overall survival beyond
24 hours (14 of 35 in med/ket, 17 of 34 in sev/fent
p = 0.47), or in survival beyond 24 hrs after ROSC
(17 of 28 in med/ket, 17 of 30 in sev/fent, p = 0.80; Figure 1).
The amount of the potassium chloride/esmolol
mixture did not differ in both groups (sev/fnt 1.0 ml
[IQR 0.88 - 1.0] vs 1.0 ml [IQR 0.7 - 1.0] in med/ket,
p = 0.25). The time to achieve ROSC was shorter in
the sev/fnt group (75 [IQR 60 – 90] sec vs 91 [IQR
90 – 140] sec, p = 0.02), and there was no significant
difference between the groups in the amount of
adrenaline needed (sev/fnt 8.6 μg [IQR 7.0 - 11.0] vs 9.0
[8.0 - 11.2] in med/ket, p = 0.50). Blood pressure varied
during the first 20 minutes after ROSC (p < 0.01) similarly
in the two groups, although the sev/fnt group had a more
severe initial hypotension early after ROSC (Figure 2).
After ROSC both groups were briefly hypothermic,
but normalized the body temperature within 20 minutes
after ROSC (Figure 3). In the first blood gas analysis
(BGA) after insertion of the arterial line, before cardiac
arrest and adjustments in ventilation, animals in the sev/fnt
group had respiratory alkalosis (pH 7.56 [IQR 7.50 – 7.60]
vs 7.42 [7.37 – 7.46] in med/ket, p < 0.01; pCO2 26.0
[22.5 – 31.5] mmHg in sev/fnt vs. 39.5 [32.8 – 48.0] mmHg
in med/ket, p < 0.01; base excess 2.1 [1.3 – 2.7] in sev/fnt vs
0.2 [−2.0 – 2.6] in med/ket, p = 0.05), increased blood
lactate (1.7 [1.5 – 2.0] mmol/l in sev/fnt vs. 0.7 [0.6 – 0.9]
mmol/l in med/ket, p < 0.01), and higher pO2 values (190
[163 – 229] mmHg in sev/fnt vs. 124 [93 – 154] mmHg in
med/ket, p < 0.01) compared to the med/ket group. To
spare blood, no further BGAs were drawn after ventilator
adjustments and before CA, we assumed identical
metabolic and similar respiratory status (because low
pCO2 with accompanying alkalosis shifts the ubiquitous
lactate-pyruvate dehydrogenase toward the lactate, this
increases the measured lactate, but is per definition no
lactic acidosis, and no metabolic derangement). Both
groups recovered similarly from metabolic and respiratory
acidosis between ROSC +5 min and +15 min (Table 1).
Glucose was significantly higher at baseline (18.0
[IQR 15.0 – 19.4] mmol/l in med/ket vs. 10.1 [9.5– 11.7]
mmol/l in sev/fnt, p < 0.01) and all later time points in the
med/ket group (Table 1).
Animals lost weight initially, but recovered similarly in
both groups. The Neuro Deficit Score, Vertical Pole Test
and Tape Removal Test demonstrated a decreasedperformance from baseline with recovery at the last
assessment day without differences between anesthetic
groups. In those animals surviving 5 days, no changes
occurred between day 2 and day 5. In the open field, in
both anesthetic groups the numbers of rears decreased
significantly after cardiac arrest without recovery after day
2. The numbers of squares crossed was similar if assessed
during baseline, day 1 and last assessment in both groups.
In those animals surviving for 5 days the assessment
of numbers of squares crossed after day 2 demonstrated a
reduced mobility in the medetomidine/ketamine group
(p = 0.04; Table 2).
Histologic examinations (cell count) and histomorpho-
metry (cell layer area) demonstrated a highly significant
inverse correlation between both methods (p < 0.01,
correlation coefficient < −0.8), especially in the two most
rostral sections of the hippocampus CA1 segment, where
most of the damage should be expected [19]. There
was no apoptosis on day 2 in either group. On day 5,
significantly more cells with pyknotic nuclei could be
found in the rostral and caudal parts of the animals
in the sevoflurane group (Table 3). This difference did
not translate into variable cell layer thickness on day
5 (Table 3), although the cell layer stratum decreased
between day 2 to day 5 (see Table 4 and Figure 4).
The levels of cytokines in the CSF were below the
detection threshold for IL-6, TNF-α and MIP-1α.
Only MCP-1 could be detected. On Day 2 MCP-1
was 69.1 pg/ml [IQR 57.7 - 90.7] in the sev/fnt group
and 72.1 pg/ml [IQR 45.8 – 101.4] in the med/ket
group (p = 1.0) On day 5 MCP-1 was higher in the
sev/fnt group than in the med/ket group (101.4 pg/ml
[IQR 57.7 - 179.7] vs. 39.6 pg/ml [IQR 33.3 - 87.5],
respectively; p = 0.04). vs). There was no difference in
MCP-1 between Day 2 and Day 5 in either group.
Experimental cardiac arrest and cardiopulmonary
resuscitation models help to elucidate the mechanisms
of brain injury and to develop therapeutic strategies.
The role of anesthesia in these models has received
little attention despite the different neuroprotective
properties of various anesthetics. The cerebral effects
of anesthetic agents after cardiac arrest are clinically
relevant since patients who remain comatose after return of
spontaneous circulation are routinely treated with sedative
and anesthetic agents in the ICU, although not with the
combinations tested in this study. We found in our rodent
model of cardiac arrest that the choice of either medetomi-
dine and ketamine or sevoflurane and fentanyl did not
modify the overall clinical and behavioral effects of post
cardiac arrest brain damage. Nevertheless, the use of
medetomidine and ketamine compared to sevoflurane and
fentanyl decreased apoptosis in the hippocampus and
decreased the concentration of the inflammatory cytokine
MCP-1 in the CSF on day 5 post cardiac arrest.
med/ket sev/fnt
3 rat sex cluded: 
1 died during in tubation 
2 no cardiac arrest achieved 
1 died during surgery 
4 no ROSC 7 no ROSC 
14 survived < 24 h 13 survived < 24 h 
3 rats euthanasia day 1 
7 rats euthanasia day 2 
4 rats euthanasia day 5 
3 rats euthanasia day 1 
7 rats euthanasia day 2 
7 rats euthanasia day 5 
57 animals in pilotphase: 
6; 7 and 7.5 minutes cardiac arrest 
Ventricular fibrillation model tests
Sham animals for surgery and histology 
Pilot phase 
Figure 1 Flow chart of the number of animals assigned into the different groups.
Bendel et al. BMC Anesthesiology 2015, 15:2 Page 6 of 13
http://www.biomedcentral.com/1471-2253/15/2
Figure 2 Mean blood pressure at different time points. Variation of blood pressure is similar in both groups. Data are shown as means and [IQR].
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protective effects in experimental myocardial ischemia
and focal cerebral ischemia models [20,21], as well as in
human cardiac surgery [22]. In contrast, in piglet cardiac
arrest adding sevoflurane to hypothermia provided
no additional neuroprotection [23]. We found moreFigure 3 Temperature at different time points. Friedmans’s test within
there is a significant difference between both groups. Data are shown as mapoptosis with sevoflurane and fentanyl than with
medetomidine and ketamine. This suggests that the
effects of sevoflurane may depend on the model of
ischemia. Also the timing of exposure to sevoflurane
may be relevant. In a cell culture model of hypoxia,
sevoflurane was either protective, harmful or had noeach anesthesia group is significant (both p < 0.01), but at no time
eans and [IQR].
Table 1 Values of the arterial blood gas analysis 5 and 15 minutes after return of spontaneous circulation (median [IQR])
Medetomidine/ketamine Sevoflurane/fentanyl p between groups Mann–Whitney test
pH 5 min 7.03 [IQR 6.93 – 7.09] 7.03 [IQR 6.95 – 7.15] p = 0.44
15 min 7.31 [IQR 7.24 – 7.34] 7.21 [IQR 7.07 – 7.32]
p within groups Wilcoxon test p < 0.01 p < 0.01
Base excess 5 min −18.2 [IQR −20.1 – -15.6] −16.3 [IQR −19.1 – -14.3] p = 0.18
15 min −9.6 [IQR −12.0 – -7.6] −10.0 [IQR −14.4 – -8.1]
p within groups Wilcoxon test p < 0.01 p < 0.01
pCO2 [mmHg] 5 min 54.0 [IQR 39.9 – 64.3] 49.0 [IQR 42.5 – 67.5] p = 0.83
15 min 33.0 [IQR 29.8 – 38.0] 43.0 [IQR 33.0 – 53.0]
p within groups Wilcoxon test p < 0.01 p < 0.01
pO2 [mmHg] 5 min 123 [IQR 113 – 1137] 110 [IQR 97 – 124] p = 0.15
15 min 141 [IQR 99 – 157] 92 [IQR 79 – 117]
p within groups Wilcoxon test p = 0.39 p = 0.01*
Lactate [mmol/l] 5 min 8.3 [IQR 6.9 – 10.7] 7.7 [IQR 7.4 – 9.3] p = 0.86
15 min 4.0 [IQR 3.1 – 6.7] 4.5 [IQR 3.8 – 4.7]
p within groups Wilcoxon test p < 0.01 p < 0.01
Glucose [mmol/l] 5 min 22.6 [IQR 20.4 – 25.3] 14.9 [IQR 13.3 – 16.4] p < 0.01*
15 min 21.9 [IQR 19.6 – 23.7] 13.1 [IQR 12.2 – 14.5] p < 0.01*
p within groups Wilcoxon test p = 0.08 p = 0.01*
Mixed respiratory and metabolic acidosis are even distributed after cardiac arrest and corrects similarly in both groups. pO2 is lower after 15 minutes in the
sev/fnt group (significant decline from the 5 minutes value, compared to the med/ket group. Glucose values are always higher in the med/ket group due to the
medetomedine (details see text) * indicate significant differences between the anesthesia groups.
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posure [24].
An alternative explanation is that the α-agonist
medetomidine as well as the NDMA-blocker ketamine
were neuroprotective. Such protective effects have been
observed in focal ischemia model of stroke when added to
halothane [25] or compared to an glutamate receptor
antagonist [26] or different other compounds and anes-
thetics [27].
Increased hippocampal apoptosis and behavioral
impairment after circulatory arrest has been reported
by others in asphyxia-induced cardiac arrest models
[14,28]. The lack of behavioral impairment in our
model despite comparable hippocampal histological
alterations and longer circulatory arrest time is likely
to be related to lack of preceding asphyxia in our
model. Also, our low-flow time was shorter than the
low-flow times reported by others.
The shorter low-flow time in the sev/fnt group did not
translate to a better outcome. The explanation of the
shorter cardio-pulmonary resuscitation time may be better
preserved cardiac function after cardiac arrest [29]. Addition
of sevoflurane to a pentobarbital anesthesia in a similar CA
model resulted in a better cardiac function up to 24 hours
after CA, but had no beneficial effect on survival.
The distance travelled in the Open Field Test (counted
by the numbers of squares crossed) was similar in bothgroups if regarded to all time points. A small, albeit
significant difference appeared after day 2 in the recovery
phase, where the animals in the sev/fnt remained mobile
compared to the animals in the med/ket group. In view of
the reduced delayed hippocampal apoptosis in the med/
ket group a cautionary explication would be the preserved
memory in these animals, so they learned and retained the
environment and expressed less exploratory behavior. Not
in line with this explanation is the missing difference in
the number of rears, and similar results in the other
clinical tests, so this finding is rather unspecific.
Regarding the inflammatory markers in the CSF, all
markers except the proinflammatory marker MCP-1
were below the detection threshold and even MCP-1
was very low. Accordingly, the relevance of increased
MCP-1 in sev/fnt at day 5 should be interpreted with
caution. Monocyte chemoattractant protein-1 MCP-1
[also referred as chemokine (C-C motif) ligand 2 (CCL2)]
is expressed by resident CNS glial cells in response to
virtually any insults (trauma, infection, hypoxia) and
is involved in the recruitment of inflammatory cells in the
CNS [30]. Increased levels of various CSF biomarkers after
cardiac arrest have been reported in experimental cardiac
arrest models [31] and after cardiac arrest in patients. The
neurofilament light protein (NFL), total tau (t-tau) and
YKL-40 were strongly associated with outcome [32]. The
lack of more severe signs of neuroinflammation in our
Table 2 Results of the general health and neurologic tests
Medetomidine/ketamine Sevoflurane/fentanyl p between groups Mann–Whitney test
Weight [g] BL 385 [IQR 357 – 413] 380 [IQR 360 – 426] p = 0.89
day 1 375 [IQR 353 – 415] 367 [IQR 343 – 420]
day 2 360 [IQR 322 – 400] 355 [IQR 342 – 387]
day 3 359 [IQR 322 – 413] 359 [IQR 348 – 360]
day 4 369 [IQR 320 – 417] 349 [IQR 343 – 351]
day 5 370 [IQR 325 – 421] 350 [IQR 319 – 360]
Friedman & (BL, day 1 and last day, all animals) p < 0.01 p < 0.01
Friedman% (day 2–5, only animals surviving all days) p = 0.14 p = 0.58
NDS BL 0 [IQR 0 – 0] 0 [IQR 0 – 0] p = 0.34
day 1 10 [IQR 5 – 14] 5 [IQR 3 – 10]
day 2 5 [IQR 0 – 5] 0 [IQR 0 – 5]
day 3 0 [IQR 0 – 0] 0 [IQR 0 – 15]
day 4 0 [IQR 0 – 0] 0 [IQR 0 – 15]
day 5 0 [IQR 0 – 0] 0 [IQR 0 – 15]
Friedman & (BL, day 1 and last day, all animals) p < 0.01 p < 0.01
Friedman% (day 2–5, only animals surviving all days) p = 0.93 p = 0.07
OFT [n] BL 94 [IQR 75 – 110] 91 [IQR 64 – 114] p = 0.89
day 1 107 [IQR 26 – 147] 102 [IQR 52 – 163]
day 2 106 [IQR 55 – 130] 114 [IQR 81 – 158]
day 3 35 [IQR 17 – 93] 90 [IQR 63 – 135]
day 4 35 [IQR 9 – 66] 42 [IQR 13 – 148]
day 5 20 [IQR 11 – 33] 66 [IQR 23 – 138]
Friedman & (BL, day 1 and last day, all animals) p = 0.23 p = 0.76
Friedman% (day 2–5, only animals surviving all days) p = 0.04 p = 0.73
rears [n] BL 23 [IQR 17 – 29] 19 [IQR 16 – 25] p = 0.21
day 1 2 [IQR 0 – 13] 5 [IQR 1 – 12]
day 2 12 [IQR 1 – 14] 11 [IQR 4 – 19]
day 3 7 [IQR 3 – 11] 6 [IQR 3 – 11]
day 4 6 [IQR 4 – 8] 5 [IQR 0 – 13]
day 5 5 [IQR 3 – 7] 4 [IQR 0 – 13]
Friedman & (BL, day 1 and last day, all animals) p < 0.01 p = 0.02
Friedman% (day 2–5, only animals surviving all days) p = 0.21 p = 0.18
VPT BL 0 [IQR 0 – 0] 0 [IQR 0 – 0] p = 0.70
day 1 2 [IQR 1 – 2] 2 [IQR 2 – 2]
day 2 1 [IQR 1 – 2] 1 [IQR 1 – 2]
day 3 0 [IQR 0 – 1] 1 [IQR 1 – 1]
day 4 0 [IQR 0 – 0] 0 [IQR 0 – 2.0]
day 5 0 [IQR 0 – 1] 0 [IQR 0 – 1.0]
Friedman & (BL, day 1 and last day, all animals) p < 0.01 p < 0.01
Friedman% (day 2–5, only animals surviving all days) p = 0.16 p = 0.43
TRT [sec] BL 18.5 [IQR 11.5 – 23.5] 11.0 [IQR 9.5– 19.5] p = 0.12
day 1 120 [IQR 120 – 120] 120 [IQR 93.5 – 120]
day 2 55.0 [IQR 15.0 – 120] 48.0 [IQR 29.5 – 120]
day 3 32.0 [IQR 11.8 – 95] 62.0 [IQR 19.0– 120]
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Table 2 Results of the general health and neurologic tests (Continued)
day 4 46.0 [IQR 21.0 – 102.5] 28.0 [IQR 19.0– 120]
day 5 24.0 [IQR 12.3 – 96.5] 36.0 [IQR 18.0– 112]
Friedman & (BL, day 1 and last day, all animals) p < 0.01 p < 0.01
Friedman% (day 2–5, only animals surviving all days) p = 0.65 p = 0.80
Friedman test including baseline, first and last day assessments (all animals)&, and including assessment from day 2 to 5, respectively (only animals with longest
survival)%. No significant differences could be found between both anesthesia groups at baseline, and global (BL, day 1 and last day) Friedman’s tests (time effect)
did not diverge. The only difference found is a reduction in the numbers of squares crossed in the open field test during the recovery phase after day 2 in the
med/ket group, compared to the sev/fnt group, in which the animals remained mobile.
NDS: Neuro Deficit Score; OFT: Open Field Test (numbers of squares crossed in the open field); rears: number of rears in the open field; VPT: Vertical Pole Test,
TRT: Tape Removal Test.
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blood flow before the cardiac arrest and to the short dur-
ation of cardiopulmonary resuscitation after the arrest [33].
The higher glucose concentration in the med/ket group
was likely due to the α-agonist medetomidine, which
interferes with insulin secretion [34] or due to a higher
stress response to intraperitoneal injection as compared
to inhalational anesthesia. Although hyperglycemia is
considered detrimental after cardiac arrest [35], hypergly-
cemia in the med/ket group did not translate into an
overall worse outcome in our model.
The initial aBGA demonstrated a respiratory alkalosis
with consecutive higher lactate values in the sev/fnt
group, despite the same initial ventilator settings. This is
due to the better muscle relaxant properties of the
sevoflurane/fentanyl combination [36] compared to
medetomidine/ketamine, resulting in smoother ventilation
and less animal-ventilator asynchrony. We assumed
normal aBGA in both groups after adaptation of the
ventilation because after resuscitation the values were
similar. We considered the maintenance of blood volume
as a priority against the verification of full normalization
of blood gases, therefore the pre-correction aBGA was not
included in the time series analysis.
The 27 animals surviving less than 24 hours died in the
early post-resuscitation phase, after presenting a rapid
shallow breathing pattern. This indicates atelectasis, but
could also be a sign of progressive cardiac failure and
cardiovascular collapse. In later experiments, performed
after finishing this series, we increased ventilation time
after ROSC for 4 hours and by doing so, we were able to
eliminate early death after ROSC.Table 3 Results of the histology analysis of the rostral and ca
day 5
Cell layer (ratio area/length)
Med/ket Sev/fnt
CA1 rostral 0.058 [0.055 – 0.064] 0.055 [0.030 – 0.065]
CA1 caudal 0.093 [0.081 – 0.108] 0.110 [0.090 – 0.110]
On day 2, there were virtually no cells with pyknotic nuclei. Data are shown as med
differences. The “thickness” of the cell layer was normalized as ratio of the area andOur study has limitations. The assignment into the
different groups was not randomized for logistic reasons.
Since the animals were assigned to the different duration
of follow-up before the experiment, a potential bias
of less severe injury in the longer follow-up could be
avoided.
Another limitation is the use of two anesthetic regimes
rather than two anesthetics, but this cannot be avoided.
So we cannot assure equipotent doses of anesthetics, the
same is true for pharmacokinetic and pharmacodynamic
effects. The effect of med/ket seemed to last longer than
sev/fnt because post resuscitation we never needed any
re-dosing of med/ket, but all animals in the sev/fnt
group received sevoflurane at a low dose of 0.6 to 0.8%
to avoid excessive hypertension and fighting against the
ventilator. The slightly lower blood pressure during the
experiment in the sev/fnt group is not significantly
different than in the med/ket group. We cannot exclude
the nonsignificant difference in blood-pressure contributes
to the difference seen in the results, but this seems rather
unlikely.
The study was not designed to quantify neuroprotective
effects of an anesthetic or an anesthetic combination after
cardiac arrest, so the difference in the apoptosis rate
is the sum effect of both anesthetic combinations on
possible precondition, hemodynamic effects (during
and post-resuscitation), low-flow time and possible
postconditioning.
Post resuscitation care was minimal and was for example
not controlled for body temperature (beyond 20 minutes),
which is a further limitation for generability in this
study. A longer post resuscitation period would haveudal sections of the CA1 segment of the hippocampus on
Day 5
Pyknotic cells %
p Med/ket Sev/fnt p
0.65 19 [7 – 28] 85 [60 – 88] 0.01*
0.32 4 [1 – 21] 33 [27 – 63] 0.02*
ians and interquartile range in square brackets [], *denotes significant
the length of the examined part (see Methods section).
Table 4 time course of the decrease of the CA1 cell layer area as a marker of atrophy
Cell layer (ratio area/length)
Med/ket Sev/fnt
Day 2 Day 5 p Day 2 Day 5 p
CA1 rostral 0.085 [0.070 – 0.090] 0.058 [0.055 – 0.064] <0.01* 0.075 [0.070 – 0.080] 0.055 [0.030 – 0.065] <0.01*
CA1 caudal 0.125 [0.120 – 0.135] 0.093 [0.081 – 0.108] < 0.01* 0.120 [0.105 – 0.123] 0.110 [0.090 – 0.110] 0.30
Data are shown as medians and interquartile range in square brackets [], *denotes significant differences. The “thickness” of the cell layer was normalized as ratio
of the area and the length of the examined part (see Methods section).
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for re-dosing of med/ket would be more difficult than
with sevoflurane.
The overall survival of 53% beyond 24 hrs indicates
that our model is quite severe, and it is possible that
the lack of histology and CSF analysis in the early
dying animals missed some of the typical changes reported
by others. The small number of animals per group is
another limitation.
The lack of consistent differences in the functional tests
might be explained by insensitivity of the behavioral tests
for detecting hippocampal CA1 related dysfunction, where
learning and memory abnormalities can be expected [37].
If the use of more elaborate tests (Morris water maze,
novel object recognition and location memory) would
have changed the results remains speculative; the smallFigure 4 Example of injury to the hippocampus (cresyl violet staining
slides of one hemisphere are showing the different sections of the CA1 seg
(starting up-left, up-right, down-left and down-right). Delineating the border o
curvature of the hippocampus. The inlays demonstrate the shrunken and pyk
arrest animal (400x). Histomorphometric analysis of the CA1 segment was per
(details see Methods). The sham animal was operated in the pilot phase, and
subjected to cardiac arrest.number of animals might also explain the absence of
a detectable difference in the functional tests.
Extrapolation to clinical cardiac arrest is limited, since
we used these anesthetics already before the cardiac arrest.
The impact of these anesthetic agents, when administered
first after the ROSC should be addressed in future studies.
Although our experiment explored neurologic function
in a model of cardiac arrest, the results have implication
for other animal models of neurological insults as stroke
or traumatic brain injury: the choice of anesthetics should
be taken into account in the design and interpretation.
Based on our study we propose, depending on the design
and research question, to introduce a second control
group with a different anesthetic regime to rule out the
possibility that the results are biased by the effects and
side effects of the anesthetic regime.). Left: sham animal, right: 8 minutes cardiac arrest. The 4 different
ment of the hippocampus while moving from rostral to caudal
f the CA1 segments is difficult in the caudal sections because of the
notic neurons, resulting in a diminished cell layer of CA1 in the cardiac
formed by 1. cell count and 2. automated surface area calculation
received complete surgery under sev/fnt anesthesia, but was not
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No difference in neurological function could be detected
on day 5 post cardiac arrest between the anesthetic
groups in our rat cardiac arrest resuscitation model.
Sevoflurane/fentanyl seem to have no neuroprotective
effect as compared to ketamine/medetomidine, based on
the lower apoptosis rate. The more prominent apoptosis
with sevoflurane/fentanyl indicates that the method of
anesthesia should be considered in interpreting the
results of experimental models of cardio-pulmonary
resuscitation.
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